Hims & Hers Health Faces Securities Class Action Deadline
Investors who purchased Hims & Hers Health securities between August 2025 and July 2026 have until November 2, 2026, to file for lead plaintiff status in a pending class action lawsuit.
A legal deadline has been set for shareholders of Hims & Hers Health, Inc. (NYSE: HIMS) to participate in a class action lawsuit. Investors who acquired company securities during the period spanning August 4, 2025, through July 29, 2026, must submit applications to serve as lead plaintiff by November 2, 2026.
The litigation, filed by Robbins Geller Rudman & Dowd LLP, centers on allegations regarding the company’s disclosures during the specified timeframe. Legal representatives claim that the firm failed to provide accurate information to shareholders, potentially influencing investment decisions.
Investors who incurred losses during this period are eligible to review their legal options. The court will evaluate applications from shareholders to lead the proceedings, a role that involves representing the interests of the broader class of investors affected by the alleged decline in share value.